AI & Emerging Technology

TPH Academy's new Chief Growth Officer isn't just a new hire; he's a signal of intent. Steve Sanders brings a playbook for scaling that could reshape the market.

As Prime Medicine prepares for a key investor conference, its next-gen 'search and replace' gene editing technology faces a crucial test. Can it deliver on its promise?

Top 20 firm Cherry Bekaert partners with Fieldguide for a massive agentic AI deployment, signaling a major industry shift from point tools to AI-native platforms.

A new free tool promises to arm security providers with an attacker's-eye view, but its real impact may be in reshaping the competitive landscape.

With over 80% of AI projects failing to launch, one firm is betting on a radical new model: guaranteed production systems at a fixed price.

A parent-founded nonprofit is funding a landmark gene therapy trial, aiming to create the first-ever treatment for a rare neurodevelopmental disorder.

A new partnership aims to extend modern identity security to legacy systems and AI agents, tackling the industry's most persistent and vulnerable gaps.

Perspective Therapeutics is testing a potent alpha-particle therapy for meningioma, the most common brain tumor, offering a new option where surgery fails.

DNV verifies Carbon Ridge’s compact OCCS hits 98% CO2 capture, offering shipowners a viable path to decarbonize existing fleets without major overhauls.

As the world grapples with drug-resistant bacteria, an Israeli biotech is testing a novel drug that physically destroys pathogens. Can it turn the tide?

Discover how advanced tech and cultural storytelling merge in Peppercorns' 'Between Mountains and Seas,' creating a cyberpunk-like oasis in Singapore.

A new radar-based system promises to make security checks faster and less invasive. But can it truly balance our demands for safety, efficiency, and privacy?

The Claims Conference's 'Benno's Light' uses mixed-reality to preserve a survivor's testimony, offering an intimate, accessible history lesson for a digital age.

Microsoft 365 Copilot's AI gets a crucial upgrade. A new Dun & Bradstreet integration provides verified business data, tackling AI's trust deficit.

Velocity Financial's new CTO, Dean Thevaos, isn't just a personnel change. It's a strategic bet on a complete tech overhaul to redefine its competitive edge.

The retirement of 25-year veteran Tracy Skeans prompts Yum! Brands to split its COO role, creating a Chief Scale Officer to drive tech and global growth.

A simple game of Solitaire is now a tool for marine conservation. It's the new frontier where entertainment meets impact, mobilizing millions for the planet.

With $11M from a16z, Westmag is building a domestic supply of drone motors and robot actuators, tackling a critical national security vulnerability.

As Rise Therapeutics advances its oral drug R-2487, it’s not just developing another pill. It’s testing a radical new idea: resetting the immune system.

Keysight's new RF signal analyzers promise to slash development time for 5G and beyond. But are they the definitive answer to the complexity crisis facing engineers?